EV/EBITDA
-3.57
0.000.00%
29 min ago
Summary
- As of March 12, 2025, KALV EV/EBITDA is -3.57, unchanged from the previous trading day.
- Over the past year, KALV EV/EBITDA has increased by +0.59 (+14.18%).
- KALV EV/EBITDA is now -339.60% below its all-time high of 1.49.
Performance
KALV EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
KALV EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | +0.2% | +0.2% |
| 1 m1 month | -33.7% | +33.6% | +31.1% |
| 3 m3 months | -44.0% | +44.1% | +40.5% |
| 6 m6 months | -22.3% | +36.0% | +19.0% |
| ytdytd | -46.9% | +47.0% | +43.1% |
| 1 y1 year | +14.2% | +13.4% | -0.3% |
| 5 y5 years | -23.1% | +372.9% | +59.0% |
KALV EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -33.7% | -3.57 | at low | |
| 3 m | 3-month | -2.04 | -75.0% | -3.57 | at low |
| 6 m | 6-month | -2.04 | -75.0% | -3.57 | at low |
| 1 y | 1-year | -2.04 | -75.0% | -4.90 | +27.1% |
| 3 y | 3-year | -0.72 | -395.8% | -4.95 | +27.9% |
| 5 y | 5-year | -0.72 | -395.8% | -20.76 | +82.8% |
| alltime | all time | 1.49 | -339.6% | -22.62 | +84.2% |
KalVista Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.57(+46.9%) |
| 2024 | -2.43(-32.5%) |
| 2023 | -3.60(+88.5%) |
| 2022 | -1.91(-50.8%) |
| 2021 | -3.88(-42.4%) |
| Date | Value |
|---|---|
| 2020 | -6.74(-17.8%) |
| 2019 | -8.20(-29.1%) |
| 2018 | -11.56(+265.8%) |
| 2017 | -3.16(+92.7%) |
| 2016 | -1.64(-16.3%) |
| 2015 | -1.96 |
FAQ
- What is KalVista Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for KalVista Pharmaceuticals?
- What is KALV EV/EBITDA year-to-date change?
- What is KalVista Pharmaceuticals EV/EBITDA year-on-year change?
What is KalVista Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of KALV is -3.57
What is the all time high EV/EBITDA for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high EV/EBITDA is 1.49
What is KALV EV/EBITDA year-to-date change?
KalVista Pharmaceuticals EV/EBITDA has changed by -1.14 (-46.91%) since the beginning of the year
What is KalVista Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, KALV EV/EBITDA has changed by +0.59 (+14.18%)